MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2020.586124

Медицинская библиотека · Frontiers in immunology · 2020

Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.

Sanchez Jorge, Gonçalves Elena, Llano Anuska, Gonzáles Pedro, Fernández-Maldonado María, Vogt Annika, Soria Angele, Perez Susana, Cedeño Samandhy, Fernández Marco Antonio, Nourikyan Julien, de Bernard Simon, Ganoza Carmela, Pedruzzi Eric, Bonduelle Olivia, Mothe Beatriz, Gòmez Carmen E, Esteban Mariano, Garcia Felipe, Lama Javier R, Brander Christian, Combadiere Behazine

Клиническое исследование I фазыСтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Our previous work has demonstrated the benefits of transcutaneous immunization in targeting Langerhans cells and preferentially inducing CD8 T-cell responses.

METHODS

In this randomized phase Ib clinical trial including 20 HIV uninfected volunteers, we compared the safety and immunogenicity of the MVA recombinant vaccine expressing HIV-B antigen (MVA-B) by transcutaneous and intramuscular routes. We hypothesized that the quality of innate and adaptive immunity differs according to the route of immunization and explored the quality of the vector vaccine-induced immune responses. We also investigated the early blood transcriptome and serum cytokine levels to identify innate events correlated with the strength and quality of adaptive immunity.

RESULTS

We demonstrate that MVA-B vaccine is safe by both routes, but that the quality and intensity of both innate and adaptive immunity differ significantly. Transcutaneous vaccination promoted CD8 responses in the absence of antibodies and slightly affected gene expression, involving mainly genes associated with metabolic pathways. Intramuscular vaccination, on the other hand, drove robust changes in the expression of genes involved in IL-6 and interferon signalling pathways, mainly those associated with humoral responses, and also some levels of CD8 response.

CONCLUSION

Thus, vaccine delivery route perturbs early innate responses that shape the quality of adaptive immunity.

CLINICAL TRIAL REGISTRATION: http://ClinicalTrials.gov, identifier PER-073-13.

Для цитирования: Sanchez Jorge, Gonçalves Elena, Llano Anuska, Gonzáles Pedro, Fernández-Maldonado María, Vogt Annika, Soria Angele, Perez Susana, Cedeño Samandhy, Fernández Marco Antonio, Nourikyan Julien, de Bernard Simon, Ganoza Carmela, Pedruzzi Eric, Bonduelle Olivia, Mothe Beatriz, Gòmez Carmen E, Esteban Mariano, Garcia Felipe, Lama Javier R, Brander Christian, Combadiere Behazine. Immune Profiles Identification by Vaccinomics After MVA Immunization in Randomized Clinical Study.. Frontiers in immunology. 2020. DOI: 10.3389/fimmu.2020.586124.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.